Tommaso Simoncini, Nils Schoof, Siir Su Saydam, Cecilia Caetano, Cecile Janssenswillen, Megan Scott, Mia Harvey, Carsten Moeller, Katrin Schaudig, Victoria Banks
{"title":"内分泌辅助治疗对乳腺癌妇女绝经期症状负担和生活质量的影响:来自realize研究的发现","authors":"Tommaso Simoncini, Nils Schoof, Siir Su Saydam, Cecilia Caetano, Cecile Janssenswillen, Megan Scott, Mia Harvey, Carsten Moeller, Katrin Schaudig, Victoria Banks","doi":"10.1016/j.maturitas.2023.04.163","DOIUrl":null,"url":null,"abstract":"Background: Women receiving endocrine adjuvant (EA) therapy after breast cancer treatment report high rates of menopausal symptoms including vasomotor symptoms (VMS). VMS impact quality of life and can lead to treatment discontinuation and reduced survival, but existing literature evaluating symptom burden and impact is limited. The REAL-world evIdence on vasomotor and other Symptoms in menopausal womEn (REALISE) study aimed to evaluate physician and patient perceptions of symptom burden and impact in women experiencing VMS while receiving EA therapy for breast cancer.","PeriodicalId":94131,"journal":{"name":"Maturitas","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Menopausal symptom burden and quality of life in women with breast cancer on endocrine adjuvant therapy: findings from the REALISE study\",\"authors\":\"Tommaso Simoncini, Nils Schoof, Siir Su Saydam, Cecilia Caetano, Cecile Janssenswillen, Megan Scott, Mia Harvey, Carsten Moeller, Katrin Schaudig, Victoria Banks\",\"doi\":\"10.1016/j.maturitas.2023.04.163\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Women receiving endocrine adjuvant (EA) therapy after breast cancer treatment report high rates of menopausal symptoms including vasomotor symptoms (VMS). VMS impact quality of life and can lead to treatment discontinuation and reduced survival, but existing literature evaluating symptom burden and impact is limited. The REAL-world evIdence on vasomotor and other Symptoms in menopausal womEn (REALISE) study aimed to evaluate physician and patient perceptions of symptom burden and impact in women experiencing VMS while receiving EA therapy for breast cancer.\",\"PeriodicalId\":94131,\"journal\":{\"name\":\"Maturitas\",\"volume\":\"19 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Maturitas\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.maturitas.2023.04.163\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Maturitas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.maturitas.2023.04.163","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Menopausal symptom burden and quality of life in women with breast cancer on endocrine adjuvant therapy: findings from the REALISE study
Background: Women receiving endocrine adjuvant (EA) therapy after breast cancer treatment report high rates of menopausal symptoms including vasomotor symptoms (VMS). VMS impact quality of life and can lead to treatment discontinuation and reduced survival, but existing literature evaluating symptom burden and impact is limited. The REAL-world evIdence on vasomotor and other Symptoms in menopausal womEn (REALISE) study aimed to evaluate physician and patient perceptions of symptom burden and impact in women experiencing VMS while receiving EA therapy for breast cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
